CC
GMED icon

Clearline Capital’s Globus Medical GMED Stock Holding History

Clearline Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-148,472
Closed -$8.5M – 118
2025
Q3 		$8.5M Buy
148,472
+114,917
+342% +$6.62M 0.39% 57
2025
Q2 		$1.98M Buy
+33,555
New +$2.17M 0.07% 83
2024
Q4 		– Sell
-63,777
Closed -$4.56M – 120
2024
Q3 		$4.56M Sell
63,777
-251,192
-80% -$17.7M 0.19% 71
2024
Q2 		$21.6M Sell
314,969
-166,635
-35% -$9.96M 0.6% 14
2024
Q1 		$25.8M Buy
481,604
+140,149
+41% +$7.53M 1.26% 13
2023
Q4 		$18.2M Buy
341,455
+60,852
+22% +$2.97M 1.12% 16
2023
Q3 		$13.9M Buy
+280,603
New +$15.7M 1.2% 27

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clearline Capital's GMED Position: Q4 2025 in Review

Clearline Capital sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 148,472 shares — an estimated $8.5M sold.

Clearline Capital first reported a position in GMED in Q3 2023 and held it in 7 quarters. The position peaked at $25.8M in Q1 2024. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Clearline Capital reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Clearline Capital sold 148,472 Globus Medical shares in Q4 2025, an estimated $8.5M.
  • Clearline Capital first reported a position in Globus Medical in Q3 2023 and held it in 7 quarters.
  • Clearline Capital's Globus Medical position peaked at $25.8M in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Clearline Capital's 13F filing for Q4 2025, filed 17 Feb 2026.